Literature DB >> 12118380

Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1.

Barbara C Godthelp1, Fré Artwert, Hans Joenje, Małgorzata Z Zdzienicka.   

Abstract

Fanconi anemia is a hereditary cancer susceptibility disorder characterized at the cellular level by spontaneous chromosomal instability and specific hypersensitivity to DNA cross-linking agents such as mitomycin C. This phenotype suggests a possible role for the Fanconi anemia proteins in the repair of DNA lesions induced by these agents, but the molecular mechanism underlying the defect in this disorder has not yet been identified. Here, we show that amongst eight so far identified complementation groups of Fanconi anemia, only fibroblasts derived from group D1 are defective in the formation of nuclear Rad51 foci after X-ray irradiation or mitomycin C treatment. This indicates that the FANCD1 gene product is uniquely involved in the assembly and/or stabilization of the Rad51 complex. Since DNA damage-induced Rad51 nuclear foci are thought to reflect repair of DNA double-strand breaks by homologous recombination, our results suggest that FANCD1 is likely to be involved in homologous recombination-dependent repair.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12118380     DOI: 10.1038/sj.onc.1205656

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  Molecular cross-talk among chromosome fragility syndromes.

Authors:  Jordi Surrallés; Stephen P Jackson; Maria Jasin; Michael B Kastan; Stephen C West; Hans Joenje
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

2.  RAD51 localization and activation following DNA damage.

Authors:  Madalena Tarsounas; Adelina A Davies; Stephen C West
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-01-29       Impact factor: 6.237

3.  Enhancement of synthetic lethality via combinations of ABT-888, a PARP inhibitor, and carboplatin in vitro and in vivo using BRCA1 and BRCA2 isogenic models.

Authors:  Caroline C Clark; Jeffrey N Weitzel; Timothy R O'Connor
Journal:  Mol Cancer Ther       Date:  2012-07-09       Impact factor: 6.261

Review 4.  Molecular pathogenesis of Fanconi anemia.

Authors:  Natalie Collins; Gary M Kupfer
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 5.  Mouse models of Fanconi anemia.

Authors:  Kalindi Parmar; Alan D'Andrea; Laura J Niedernhofer
Journal:  Mutat Res       Date:  2009-04-10       Impact factor: 2.433

6.  Radiation enhances caspase 3 cleavage of Rad51 in BRCA2-defective cells.

Authors:  Erika T Brown; Cheryl Robinson-Benion; Jeffrey T Holt
Journal:  Radiat Res       Date:  2008-05       Impact factor: 2.841

7.  Overexpression of RAD51 occurs in aggressive prostatic cancer.

Authors:  Anita Mitra; Charles Jameson; Yolanda Barbachano; Lydia Sanchez; Zsofia Kote-Jarai; Susan Peock; Nayanta Sodha; Elizabeth Bancroft; Anne Fletcher; Colin Cooper; Douglas Easton; Rosalind Eeles; Christopher S Foster
Journal:  Histopathology       Date:  2009-12       Impact factor: 5.087

8.  Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells.

Authors:  Kazuhiko Yamamoto; Masamichi Ishiai; Nobuko Matsushita; Hiroshi Arakawa; Jane E Lamerdin; Jean-Marie Buerstedde; Mitsune Tanimoto; Mine Harada; Larry H Thompson; Minoru Takata
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  Purified human BRCA2 stimulates RAD51-mediated recombination.

Authors:  Ryan B Jensen; Aura Carreira; Stephen C Kowalczykowski
Journal:  Nature       Date:  2010-10-07       Impact factor: 49.962

10.  RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation.

Authors:  Sophie Badie; Chunyan Liao; Maria Thanasoula; Paul Barber; Mark A Hill; Madalena Tarsounas
Journal:  J Cell Biol       Date:  2009-05-18       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.